Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Assets Average (2016 - 2025)

Vanda Pharmaceuticals' Assets Average history spans 15 years, with the latest figure at $545.0 million for Q4 2025.

  • On a quarterly basis, Assets Average fell 16.23% to $545.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $545.0 million, a 16.23% decrease, with the full-year FY2025 number at $572.6 million, down 12.22% from a year prior.
  • Assets Average hit $545.0 million in Q4 2025 for Vanda Pharmaceuticals, down from $612.9 million in the prior quarter.
  • Over the last five years, Assets Average for VNDA hit a ceiling of $652.0 million in Q2 2024 and a floor of $538.3 million in Q1 2021.
  • Historically, Assets Average has averaged $615.2 million across 5 years, with a median of $628.2 million in 2022.
  • Biggest five-year swings in Assets Average: grew 12.21% in 2021 and later decreased 16.23% in 2025.
  • Tracing VNDA's Assets Average over 5 years: stood at $586.8 million in 2021, then grew by 7.03% to $628.0 million in 2022, then rose by 2.71% to $645.0 million in 2023, then rose by 0.87% to $650.7 million in 2024, then dropped by 16.23% to $545.0 million in 2025.
  • Business Quant data shows Assets Average for VNDA at $545.0 million in Q4 2025, $612.9 million in Q3 2025, and $628.3 million in Q2 2025.